Yes, the charts tell a dismal story and the 2 updates re Phosphate and Peru, followed by the quarterly have not supported the sp.
What is lacking is specific news - ie assays.
The quarterly detailed assays expected early in 1st quarter 2023 - hello - we are past early.
Maybe this was repeating a comment from last year - if so all it does is highlight it did not happen.
[the rock breaker approach strikes again]
Further into the quarterly, assays expected in coming weeks - it would be great if released by mid Feb.
Meanwhile buyers are positioning themselves @ 2c to take advantage of any delay re the assays.
Hopefully it does not go sub 2c - there is still just over 1m shares wanted at 2.1 2.2
Add to My Watchlist
What is My Watchlist?
